Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endotoxin and Cytokine Adsorption Properties of the Oxiris Hemofilter in Septic Shock: Evaluation of Saturation Phenomena and Inflammatory Mediators' Clearance Capacity

NCT07419802 is registered in ClinicalTrials.gov with Pauls Stradins Clinical University Hospital as lead sponsor.

NCT NCT07419802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07419802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endotoxin and Cytokine Adsorption Properties of the Oxiris Hemofilter in Septic Shock: Evaluation of Saturation Phenomena and Inflammatory Mediators' Clearance Capacity
Lead sponsor
Pauls Stradins Clinical University Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2026
Completion date
September 1, 2027
Enrollment
29 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood purification, hemoadsorption, sepsis, septic shock